Allergen-specific intralymphatic immunotherapy in human and animal studies

Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seon Tae, Park, So Hyun, Lee, Sang Min, Lee, Sang Pyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2017
Materias:
Current Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537077/
https://www.ncbi.nlm.nih.gov/pubmed/28765817
http://dx.doi.org/10.5415/apallergy.2017.7.3.131
_version_ 1783254102635970560
author Kim, Seon Tae
Park, So Hyun
Lee, Sang Min
Lee, Sang Pyo
author_facet Kim, Seon Tae
Park, So Hyun
Lee, Sang Min
Lee, Sang Pyo
author_sort Kim, Seon Tae
collection PubMed
description Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several animal studies of ILIT have been conducted in the form of translational or veterinary research. We conducted a literature review to examine the treatment efficacy and adverse effects of ILIT.
format Online
Article
Text
id pubmed-5537077
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Asia Pacific Association of Allergy, Asthma and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-55370772017-08-01 Allergen-specific intralymphatic immunotherapy in human and animal studies Kim, Seon Tae Park, So Hyun Lee, Sang Min Lee, Sang Pyo Asia Pac Allergy Current Review Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several animal studies of ILIT have been conducted in the form of translational or veterinary research. We conducted a literature review to examine the treatment efficacy and adverse effects of ILIT. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2017-07 2017-07-19 /pmc/articles/PMC5537077/ /pubmed/28765817 http://dx.doi.org/10.5415/apallergy.2017.7.3.131 Text en Copyright © 2017. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Current Review
Kim, Seon Tae
Park, So Hyun
Lee, Sang Min
Lee, Sang Pyo
Allergen-specific intralymphatic immunotherapy in human and animal studies
title Allergen-specific intralymphatic immunotherapy in human and animal studies
title_full Allergen-specific intralymphatic immunotherapy in human and animal studies
title_fullStr Allergen-specific intralymphatic immunotherapy in human and animal studies
title_full_unstemmed Allergen-specific intralymphatic immunotherapy in human and animal studies
title_short Allergen-specific intralymphatic immunotherapy in human and animal studies
title_sort allergen-specific intralymphatic immunotherapy in human and animal studies
topic Current Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537077/
https://www.ncbi.nlm.nih.gov/pubmed/28765817
http://dx.doi.org/10.5415/apallergy.2017.7.3.131
work_keys_str_mv AT kimseontae allergenspecificintralymphaticimmunotherapyinhumanandanimalstudies
AT parksohyun allergenspecificintralymphaticimmunotherapyinhumanandanimalstudies
AT leesangmin allergenspecificintralymphaticimmunotherapyinhumanandanimalstudies
AT leesangpyo allergenspecificintralymphaticimmunotherapyinhumanandanimalstudies

Ejemplares similares